Cargando…
Considerations for the Nonclinical Safety Evaluation of Antibody–Drug Conjugates
The targeted delivery of drugs by means of linking them to antibodies (Abs) to form antibody–drug conjugates (ADCs) has become an important approach in oncology and could potentially be used in other therapeutic areas. Targeted therapy is aimed at improving clinical efficacy while minimizing adverse...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167597/ https://www.ncbi.nlm.nih.gov/pubmed/33921632 http://dx.doi.org/10.3390/antib10020015 |